Nested high-resolution melting curve analysis a highly sensitive, reliable, and simple method for detection of JAK2 exon 12 mutations--clinical relevance in the monitoring of polycythemia.
暂无分享,去创建一个
S. Carillo | R. Kralovics | E. Lippert | F. Girodon | S. Hermouet | T. Lavabre‐Bertrand | E. Jourdan | C. Cleyrat | L. Henry | I. Guiraud | Céline Richard | Frédérique Dubois Galopin
[1] V. Ugo,et al. Interlaboratory Development and Validation of a HRM Method Applied to the Detection of JAK2 Exon 12 Mutations in Polycythemia Vera Patients , 2010, PloS one.
[2] F. Rodeghiero,et al. Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: Report of a new mutation , 2009, American journal of hematology.
[3] T. Haferlach,et al. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera , 2009, Haematologica.
[4] I. Rapado,et al. High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms. , 2009, The Journal of molecular diagnostics : JMD.
[5] A. Green,et al. Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis , 2008, Haematologica.
[6] R. Kralovics,et al. Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations. , 2008, Blood.
[7] J. Gécz,et al. Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients , 2008, Leukemia.
[8] M. Cazzola,et al. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. , 2008, Blood.
[9] M. Cazzola. Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis , 2007, Haematologica.
[10] B. Bellosillo,et al. JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis , 2007, Haematologica.
[11] A. Green,et al. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels , 2007, Haematologica.
[12] A. Green,et al. Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera , 2007, British journal of haematology.
[13] A. Tefferi,et al. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera , 2007, Leukemia.
[14] M. Stratton,et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. , 2007, The New England journal of medicine.
[15] François Girodon,et al. The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. , 2006, Blood.
[16] C. Wittwer,et al. Quantitative heteroduplex analysis for single nucleotide polymorphism genotyping. , 2005, Analytical biochemistry.
[17] Stefan N. Constantinescu,et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.
[18] Mario Cazzola,et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.
[19] Sandra A. Moore,et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.
[20] P. Campbell,et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.
[21] 松山 智洋. What's going on 造血器腫瘍 A gain-of-function mutation of JAK2 in myeloproliferative disorders. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. N Engl J Med. 2005; 352: 1779-90. PMID:15858187.--慢性骨髄増殖性疾患においてJAK2遺伝子の変異が高頻度にみられることを示した論文 , 2005 .